Significant Insider Buying in Health Care Sector Fund Revealed
A recent analysis of the weighted holdings within The Health Care Select Sector SPDR Fund (XLV) indicates that 10.5% of its holdings have seen insider buying over the last six months. This reflects a notable trend among company insiders investing in their own firms, suggesting confidence in future performance.
Insights into Moderna Inc. (MRNA)
Moderna Inc. (Symbol: MRNA), which makes up 0.22% of the Health Care Select Sector SPDR Fund, has seen director and officer buy-ins recently. According to Forms 4 data, two insiders made purchases in the past six months. The total value of MRNA held in the ETF stands at $84,254,382, placing it as the 51st largest holding in the fund.
Recent Insider Buying Activity at MRNA
| Date | Insider | Title | Shares Purchased | Price/Share | Total Value |
|---|---|---|---|---|---|
| 03/03/2025 | Paul Sagan | Director | 31,620 | $31.76 | $1,004,251 |
| 03/03/2025 | Stephane Bancel | Chief Executive Officer | 160,314 | $31.22 | $5,004,318 |
Explore 10 ETFs With Stocks That Insiders Are Buying »
Also See:
• SYNC Historical Stock Prices
• Institutional Holders of IPHS
• KEQU Insider Buying
The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.
